<p>Double stranded oligonucleotides with Mef2 consensus sequences were designed to test SmMef2 binding requirements (A). AT14 is the negative control probe (A). An MBP-SmMef2 fusion protein was purified and tested for its ability to bind double-stranded labeled probes (oligo-pair AT12 and oligo-pair AT13) containing different Mef2 consensus sequences (B and C, respectively). Purified MBP alone does not bind the DNA probes (B and C Lanes 2), while the MBP-SmMef2 fusion protein binds the probes (B and C, Lanes 3). Unlabeled oligonucleotide pairs AT11, AT12 and AT13 compete for binding against the labeled reporters (B and C, Lanes 4–6), while nonspecific AT14 does not compete (A and B Lane 7).</p
<p>(A) Lanes 1 and 2 indicating the mobilities of labeled, biotinylated oligonucleotides (A33 and G3...
<p>Successive increases of MtrR-MBP incubated with 10 ng <i>mtrCDE</i> (A) or <i>nadA</i> (B) promot...
<p>(A) Successive increases of FarR-MBP incubated with 10 ng <i>nadA</i> promoter region to assess b...
<p>(A) Shown are the SMRE consensus sequence and eight SMRE variants. (B) EMSA showing that PtrMYB3,...
<p>All samples contained binding buffer (1.5 µL), Poly dI:dC (1.5 µL), G allele or A allele probe (0...
<p>A. EMSA analysis of TFAM binding to double-stranded oligonucleotide probes containing the C295T m...
<p><b>A.</b> 5′-end biotin-labeled double-stranded oligonucleotides probes including −462 G (lane 1–...
<p>(A) Competitive EMSAs were performed with <i>P3</i> (left) and <i>P5</i> (right) probes in NE of ...
<p><b>Panel (A)</b>: Shows the EMSA experiments to evaluate the specificity of the Oligo – Nuclear p...
<p><b>A.</b> Nucleotide sequences of M4, M5 and M5 pmut E2 probes. E-box and GC-box are underline. <...
<p><b>Panel (A)</b>: Shows the EMSA experiments carried out to assess the displacement of the probe ...
<p>M, DL2000 molecular standard; 1∼6: specific competitive reaction. The amount of FEMU2-3C2H2 ZF is...
<p>The oligonucleotide sequence used in binding test of Femu2-3C2H2 Znf by EMSA.</p
<p><b>A)</b> Outline of the selection procedure carried out to determine the DNA binding motif of Mi...
<p>Chromatin immunoprecipitation (ChIP) assays were carried out to detect <i>in vivo</i> binding of ...
<p>(A) Lanes 1 and 2 indicating the mobilities of labeled, biotinylated oligonucleotides (A33 and G3...
<p>Successive increases of MtrR-MBP incubated with 10 ng <i>mtrCDE</i> (A) or <i>nadA</i> (B) promot...
<p>(A) Successive increases of FarR-MBP incubated with 10 ng <i>nadA</i> promoter region to assess b...
<p>(A) Shown are the SMRE consensus sequence and eight SMRE variants. (B) EMSA showing that PtrMYB3,...
<p>All samples contained binding buffer (1.5 µL), Poly dI:dC (1.5 µL), G allele or A allele probe (0...
<p>A. EMSA analysis of TFAM binding to double-stranded oligonucleotide probes containing the C295T m...
<p><b>A.</b> 5′-end biotin-labeled double-stranded oligonucleotides probes including −462 G (lane 1–...
<p>(A) Competitive EMSAs were performed with <i>P3</i> (left) and <i>P5</i> (right) probes in NE of ...
<p><b>Panel (A)</b>: Shows the EMSA experiments to evaluate the specificity of the Oligo – Nuclear p...
<p><b>A.</b> Nucleotide sequences of M4, M5 and M5 pmut E2 probes. E-box and GC-box are underline. <...
<p><b>Panel (A)</b>: Shows the EMSA experiments carried out to assess the displacement of the probe ...
<p>M, DL2000 molecular standard; 1∼6: specific competitive reaction. The amount of FEMU2-3C2H2 ZF is...
<p>The oligonucleotide sequence used in binding test of Femu2-3C2H2 Znf by EMSA.</p
<p><b>A)</b> Outline of the selection procedure carried out to determine the DNA binding motif of Mi...
<p>Chromatin immunoprecipitation (ChIP) assays were carried out to detect <i>in vivo</i> binding of ...
<p>(A) Lanes 1 and 2 indicating the mobilities of labeled, biotinylated oligonucleotides (A33 and G3...
<p>Successive increases of MtrR-MBP incubated with 10 ng <i>mtrCDE</i> (A) or <i>nadA</i> (B) promot...
<p>(A) Successive increases of FarR-MBP incubated with 10 ng <i>nadA</i> promoter region to assess b...